{"name": "Isis Pharmaceuticals",
 "permalink": "isis-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/isis-pharmaceuticals",
 "homepage_url": "http://www.isispharm.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "760-931-9200",
 "description": "",
 "created_at": "Wed Dec 12 11:12:30 UTC 2012",
 "updated_at": "Tue Jun 11 03:25:40 UTC 2013",
 "overview": "\u003Cp\u003EIsis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis\u0026#8217; broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer. Isis\u0026#8217; partner, Genzyme, plans to commercialize Isis\u0026#8217; lead product, KYNAMRO\u2122, in the United States and Europe following regulatory approval. Isis\u0026#8217; patents provide strong and extensive protection for its drugs and technology.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       78],
      "assets/images/resized/0022/5033/225033v1-max-150x150.jpg"],
     [[200,
       105],
      "assets/images/resized/0022/5033/225033v1-max-250x250.jpg"],
     [[200,
       105],
      "assets/images/resized/0022/5033/225033v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2855 Gazelle Court",
    "address2": "",
    "zip_code": "92010",
    "city": "Carlsbad",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Isis earns $7.5M milestone on PhII/III trial launch",
    "stoned_year": 2013,
    "stoned_month": 2,
    "stoned_day": 20,
    "source_url": "http://www.fiercebiotech.com/story/isis-earns-75m-milestone-phiiiii-trial-launch/2013-02-20?utm_source=rss\u0026utm_medium=rss",
    "source_text": "",
    "source_description": "Isis earns $7.5M milestone on PhII/III trial launch",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Isis Pharmaceuticals",
      "permalink": "isis-pharmaceuticals"}},
   {"description": "Isis Pharmaceuticals, Inc. (ISIS) Receives $10 Million Milestone Payment ",
    "stoned_year": 2013,
    "stoned_month": 6,
    "stoned_day": 6,
    "source_url": "http://www.biospace.com/news_story.aspx?StoryID=299218\u0026full=1",
    "source_text": "",
    "source_description": "Isis Pharmaceuticals, Inc. (ISIS) Receives $10 Million Milestone Payment ",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Isis Pharmaceuticals",
      "permalink": "isis-pharmaceuticals"}},
   {"description": "Isis Pharmaceuticals receives $6m payment from AstraZeneca\r\nPBR Staff Writer",
    "stoned_year": 2013,
    "stoned_month": 6,
    "stoned_day": 10,
    "source_url": "http://contractresearch.pharmaceutical-business-review.com/news/isis-pharmaceuticals-receives-6m-payment-from-astrazeneca-100613?utm_term=Pharma\u0026utm_source=PBR\u0026utm_medium=twitter",
    "source_text": "",
    "source_description": " Isis Pharmaceuticals receives $6m payment from AstraZeneca PBR Staff Writer",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Isis Pharmaceuticals",
      "permalink": "isis-pharmaceuticals"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        106],
       "assets/images/resized/0022/5034/225034v1-max-150x150.jpg"],
      [[250,
        176],
       "assets/images/resized/0022/5034/225034v1-max-250x250.jpg"],
      [[450,
        318],
       "assets/images/resized/0022/5034/225034v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}